XML 39 R27.htm IDEA: XBRL DOCUMENT
v3.24.3

SALES SERVICE REVENUE, NET AND ACCOUNTS RECEIVABLE (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
SALES SERVICE REVENUE, NET AND ACCOUNTS RECEIVABLE [Abstract] |
Schedule of Net Revenues | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Three Months Ended September 30,
(dollars in thousands) | ​ | Diagnostic Testing
​ |  | 2024 |  | 2023
Medicaid | ​ | $ | 8 | ​ | $ | 10
Medicare | ​ |  | 1,819 | ​ |  | 1,691
Self-pay | ​ |  | 1 | ​ |  | 39
Third party payers | ​ |  | 2,743 | ​ |  | 1,998
Contract diagnostics and other | ​ |  | 28 | ​ |  | —
Service revenue, net | ​ | $ | 4,599 | ​ | $ | 3,738
​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Nine Months Ended September 30,
(dollars in thousands) | ​ | Diagnostic Testing
​ |  | 2024 |  | 2023
Medicaid | ​ | $ | 33 | ​ | $ | 22
Medicare | ​ |  | 4,435 | ​ |  | 3,736
Self-pay | ​ |  | 33 | ​ |  | 155
Third party payers | ​ |  | 6,796 | ​ |  | 4,661
Contract diagnostics and other | ​ |  | 32 | ​ |  | —
Service revenue, net | ​ | $ | 11,329 | ​ | $ | 8,574
​
Schedule of Gross to Net Sales Adjustments | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Three Months Ended September 30,
(dollars in thousands) | ​ | ​ | ​ | Contractual Allowances and | ​ | Revenues, net of Contractual
​ | ​ | Gross Revenues | ​ | adjustments | ​ | Allowances and adjustments
​ |  | 2024 |  | 2023 |  | 2024 |  | 2023 |  | 2024 |  | 2023
Medicaid | ​ | $ | 8 | ​ | $ | 10 | ​ | $ | — | ​ | $ | — | ​ | $ | 8 | ​ | $ | 10
Medicare | ​ |  | 1,819 | ​ |  | 1,693 | ​ |  | — | ​ |  | (2) | ​ |  | 1,819 | ​ |  | 1,691
Self-pay | ​ |  | 1 | ​ |  | 39 | ​ |  | — | ​ |  | — | ​ |  | 1 | ​ |  | 39
Third party payers | ​ |  | 9,356 | ​ |  | 6,956 | ​ |  | (6,613) | ​ |  | (4,958) | ​ |  | 2,743 | ​ |  | 1,998
Contract diagnostics and other | ​ |  | 28 | ​ |  | — | ​ |  | — | ​ |  | — | ​ |  | 28 | ​ |  | —
​ | ​ |  | 11,212 | ​ |  | 8,698 | ​ |  | (6,613) | ​ |  | (4,960) | ​ |  | 4,599 | ​ |  | 3,738
Product | ​ |  | 681 | ​ |  | 831 | ​ |  | — | ​ |  | — | ​ |  | 681 | ​ |  | 831
​ | ​ | $ | 11,893 | ​ | $ | 9,529 | ​ | $ | (6,613) | ​ | $ | (4,960) | ​ | $ | 5,280 | ​ | $ | 4,569
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Nine Months Ended September 30,
(dollars in thousands) | ​ | ​ | ​ | Contractual Allowances and | ​ | Revenues, net of Contractual
​ | ​ | Gross Revenues | ​ | adjustments | ​ | Allowances and adjustments
​ |  | 2024 |  | 2023 |  | 2024 |  | 2023 |  | 2024 |  | 2023
Medicaid | ​ | $ | 33 | ​ | $ | 22 | ​ | $ | — | ​ | $ | — | ​ | $ | 33 | ​ | $ | 22
Medicare | ​ |  | 4,435 | ​ |  | 3,738 | ​ |  | — | ​ |  | (2) | ​ |  | 4,435 | ​ |  | 3,736
Self-pay | ​ |  | 33 | ​ |  | 155 | ​ |  | — | ​ |  | — | ​ |  | 33 | ​ |  | 155
Third party payers | ​ |  | 23,285 | ​ |  | 16,233 | ​ |  | (16,489) | ​ |  | (11,572) | ​ |  | 6,796 | ​ |  | 4,661
Contract diagnostics | ​ |  | 32 | ​ |  | — | ​ |  | — | ​ |  | — | ​ |  | 32 | ​ |  | —
​ | ​ |  | 27,818 | ​ |  | 20,148 | ​ |  | (16,489) | ​ |  | (11,574) | ​ |  | 11,329 | ​ |  | 8,574
Product | ​ |  | 1,936 | ​ |  | 2,469 | ​ |  | — | ​ |  | — | ​ |  | 1,936 | ​ |  | 2,469
​ | ​ | $ | 29,754 | ​ | $ | 22,617 | ​ | $ | (16,489) | ​ | $ | (11,574) | ​ | $ | 13,265 | ​ | $ | 11,043
Schedule of Reported Revenues Net of Collection Allowance | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Three Months Ended September 30,
​ | ​ | Revenues, net of | ​ | ​ | ​ |
(dollars in thousands) | ​ | Contractual Allowances | ​ | Allowances for credit | ​ |
​ | ​ | and adjustments | ​ | losses | ​ | Total
​ |  | 2024 |  | 2023 |  | 2024 |  | 2023 |  | 2024 |  | 2023
Medicaid | ​ | $ | 8 | ​ | $ | 10 | ​ | $ | (3) | ​ | $ | (4) | ​ | $ | 5 | ​ | $ | 6
Medicare | ​ |  | 1,819 | ​ |  | 1,691 | ​ |  | (27) | ​ |  | (20) | ​ |  | 1,792 | ​ |  | 1,671
Self-pay | ​ |  | 1 | ​ |  | 39 | ​ |  | — | ​ |  | (3) | ​ |  | 1 | ​ |  | 36
Third party payers | ​ |  | 2,743 | ​ |  | 1,998 | ​ |  | (41) | ​ |  | (24) | ​ |  | 2,702 | ​ |  | 1,974
Contract diagnostics and other | ​ |  | 28 | ​ |  | — | ​ |  | — | ​ |  | — | ​ |  | 28 | ​ |  | —
​ | ​ |  | 4,599 | ​ |  | 3,738 | ​ |  | (71) | ​ |  | (51) | ​ |  | 4,528 | ​ |  | 3,687
Product | ​ |  | 681 | ​ |  | 831 | ​ |  | — | ​ |  | — | ​ |  | 681 | ​ |  | 831
​ | ​ | $ | 5,280 | ​ | $ | 4,569 | ​ | $ | (71) | ​ | $ | (51) | ​ | $ | 5,209 | ​ | $ | 4,518
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Nine Months Ended September 30,
​ | ​ | Revenues, net of | ​ | ​ | ​ |
(dollars in thousands) | ​ | Contractual Allowances | ​ | Allowances for credit | ​ |
​ | ​ | and adjustments | ​ | losses | ​ | Total
​ |  | 2024 |  | 2023 |  | 2024 |  | 2023 |  | 2024 |  | 2023
Medicaid | ​ | $ | 33 | ​ | $ | 22 | ​ | $ | (12) | ​ | $ | (10) | ​ | $ | 21 | ​ | $ | 12
Medicare | ​ |  | 4,435 | ​ |  | 3,736 | ​ |  | (66) | ​ |  | (43) | ​ |  | 4,369 | ​ |  | 3,693
Self-pay | ​ |  | 33 | ​ |  | 155 | ​ |  | (3) | ​ |  | (15) | ​ |  | 30 | ​ |  | 140
Third party payers | ​ |  | 6,796 | ​ |  | 4,661 | ​ |  | (102) | ​ |  | (107) | ​ |  | 6,694 | ​ |  | 4,554
Contract diagnostics and other | ​ |  | 32 | ​ |  | — | ​ |  | — | ​ |  | — | ​ |  | 32 | ​ |  | —
​ | ​ |  | 11,329 | ​ |  | 8,574 | ​ |  | (183) | ​ |  | (175) | ​ |  | 11,146 | ​ |  | 8,399
Product | ​ |  | 1,936 | ​ |  | 2,469 | ​ |  | — | ​ |  | — | ​ |  | 1,936 | ​ |  | 2,469
​ | ​ | $ | 13,265 | ​ | $ | 11,043 | ​ | $ | (183) | ​ | $ | (175) | ​ | $ | 13,082 | ​ | $ | 10,868
​ ​
Schedule of Receivables | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
(dollars in thousands) |  | September 30, 2024 |  | December 31, 2023
Medicaid | ​ | $ | 10 | ​ | $ | 25
Medicare | ​ |  | 1,850 | ​ |  | 1,561
Self-pay | ​ |  | 191 | ​ |  | 229
Third party payers | ​ |  | 1,508 | ​ |  | 1,641
Contract diagnostic services, product and other | ​ |  | 217 | ​ |  | 417
​ | ​ | $ | 3,776 | ​ | $ | 3,873
Less allowance for credit losses | ​ |  | (2,755) | ​ |  | (2,572)
Accounts receivable, net | ​ | $ | 1,021 | ​ | $ | 1,301
Schedule of Allowance for Doubtful Accounts | The following table presents the roll-forward of the allowance for credit losses for the nine months ended September 30, 2024.
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | ​ |  | Allowance for
​ | ​ | ​ | ​ | ​ | Credit
(dollars in thousands) | ​ | ​ | ​ | ​ | Losses
Balance, January 1, 2024 |  | ​ |  | ​ | $ | (2,572)
Provision for credit losses: |  | ​ |  | ​ |  |
Medicaid | ​ | $ | (12) | ​ |  |
Medicare | ​ |  | (66) | ​ |  |
Self-pay | ​ | ​ | (3) | ​ | ​ | ​
Third party payers | ​ |  | (102) | ​ |  |
​ | ​ |  | (183) | ​ |  |
Credit loss expense | ​ | $ | — | ​ |  |
Total charges | ​ |  |  | ​ |  | (183)
Balance, September 30, 2024 | ​ |  |  | ​ | $ | (2,755)
Schedule of Customer Revenue and Accounts Receivable Concentrations | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Net sales | ​ | ​ | Net sales | ​ | ​ | Accounts receivable, as of | ​
​ | ​ | Three Months Ended | ​ | ​ | Nine Months Ended | ​ | ​ | ​ | ​
​ | ​ | September 30, | ​ | ​ | September 30, | ​ | ​ | September 30, | ​ | December 31, | ​
​ | ​ | 2024 | ​ | 2023 | ​ | ​ | 2024 | ​ | 2023 | ​ | ​ | 2024 | ​ | 2023 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Customer A | ​ | * | ​ | 13 | % | ​ | * | ​ | 14 | % | ​ | * | ​ | * | ​
Customer B | ​ | * | ​ | * | ​ | ​ | * | ​ | * | ​ | ​ | * | ​ | 13 | %
Customer C | ​ | 24 | % | * | ​ | ​ | 14 | % | * | ​ | ​ | 20 | % | * | ​
Customer D | ​ | * | ​ | 12 | % | ​ | * | ​ | * | ​ | ​ | * | ​ | * | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
* represents less than 10% | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​

X
- Definition Net Sales Service Revenue and Accounts Receivable [Abstract] + References No definition available. + Details
Name: | prpo_NetSalesServiceRevenueAndAccountsReceivableAbstract
Namespace Prefix: | prpo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of Allowance for Doubtful Accounts [Table Text Block] + References No definition available. + Details
Name: | prpo_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock
Namespace Prefix: | prpo_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of Gross to Net Sales Adjustments [Table Text Block] + References No definition available. + Details
Name: | prpo_ScheduleOfGrossToNetSalesAdjustmentsTableTextBlock
Namespace Prefix: | prpo_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of Reported Revenues Net of Collection Allowance [Table Text Block] + References No definition available. + Details
Name: | prpo_ScheduleOfReportedRevenuesNetOfCollectionAllowanceTableTextBlock
Namespace Prefix: | prpo_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 16 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-16 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-21 + Details
Name: | us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration